Purchase Order HHSF223201610146P

This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Chiral Technologies Inc., a foreign-owned, for-profit manufacturer of goods. The $6,015.00 contract is for the procurement of a Chiralcel OD-H semi-preparative chromatography column, which is used for chiral separations and analysis in biomedical research. Chiral Technologies Inc. is a specialized supplier of advanced...

This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Patheon API Services, Inc. (doing business as Irix) on February 2, 2012. The contract, valued at $89,900.00, requires the production of 8 kilograms of SGS742 under current good manufacturing practice (CGMP) conditions. The contract has no set-aside designation and is scheduled for completion on April 15, 2012. Patheon API Services, Inc. is the prime contractor, and there is...

<p>This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Edelris, a for-profit manufacturer, for the delivery of 5,050 proprietary chemical compounds at 1 milligram and 2 x 1 milligram each. The total ceiling value of the contract is $126,150.00, and the ultimate completion date is March 30, 2017. The contract does not have a set-aside designation.</p>

This $5,880.00 firm fixed price purchase order was awarded by the U.S. government to Biopeptide Co., Inc., a for-profit organization, manufacturer of goods, and Subchapter S Corporation, for the custom synthesis of 25 milligrams of a BCL11A-dimethyl peptide sequence with 95% purity. The contract, which has no set-aside designation, was awarded on March 19, 2009 with a final completion date of April 12, 2009. The place of performance is San Diego, California. No additional context about the...

<p>This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian agency, to Pharsight Corporation, a small business contractor. The contract has a ceiling value of $148,999.29 and a completion date of July 14, 2016. The contract was set aside for total small business participation. The place of performance is St. Louis, MO. No additional details about the specific products or services being delivered under this contract were provided.</p>

This federal contract award, valued at $50,000.00, was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the Department of Health and Human Services, to the prime contractor Entrechem SL. The contract is for the purchase of 100 grams each of two specific enantiomers of trans-N-Boc-1,2-tetrahydro-3,4-furandiamine. These chemical compounds are needed as starting materials for the NIDDK's research into developing thyclotides, which...

This is a firm fixed price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), to Chiral Technologies Inc., a foreign-owned manufacturer of chiral separation products and services. The $56,889.50 contract is for the procurement of specialized Chiralcel OZ and Chiralpak IF preparative columns, which are used for chiral separations to support NCATS' biomedical research efforts. The award was not set...

<p>The U.S. Federal Agency, Office of Logistics and Acquisition Operations, awarded a Firm Fixed Price Purchase Order contract to 3Xper Innoventure LTD, a foreign-owned for-profit manufacturing organization, to MANUFACTURE THE SMALL MOLECULES TO INCREASE THE TRANSLATIONAL POTENTIAL. The contract has a ceiling value of $24,200.00 and a performance period ending on December 8, 2025. The contract was awarded on December 9, 2024 and does not have a set-aside designation.</p>

This is a $90,800.00 firm-fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, to Chemaxon LLC, a foreign-owned for-profit limited liability company. The contract, which has a completion date of September 29, 2023, is for the provision of ChemAxon software licenses, including JChem Oracle Cartridge, Marvin JS, JChem Base, and Instant JChem Enterprise. These specialized...

<p>This is a firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases, a civilian agency, to Asischem Inc. for the custom synthesis of Compound 8 for Robert Cragie, Building 5 Room 439. The contract has a ceiling value of $14,997.00 and was awarded on September 28, 2007, with an ultimate completion date of October 14, 2007. The contract does not have a set-aside designation.</p>